SCHEMBL29416003

SCHEMBL29416003

CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O

nearest known ligand 0.63

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ CALCR P30988 7/20 0.63
▸ RAMP3 O60896 3/20 0.63
▸ NPY2R P49146 8/20 0.62
▸ NPY4R P50391 8/20 0.62
▸ NPY5R Q15761 8/20 0.62
▸ NPY1R P25929 6/20 0.62
▸ C5AR1 P21730 1/20 0.61
▸ EP300 Q09472 1/20 0.58
▸ HIF1A Q16665 1/20 0.58
▸ GLP1R P43220 1/20 0.58
▸ GCGR P47871 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31182654 0.91 NPY2R (0.66) CALCRRAMP3NPY2RNPY4RNPY5R
SCHEMBL31182516 0.91 NPY2R (0.64) CALCRRAMP3NPY2RNPY4RNPY5R
SCHEMBL30883230 0.90 RAMP3 (0.64) CALCRRAMP3NPY2RNPY4RNPY5R
SCHEMBL30436896 0.90 CALCR (0.68) CALCRRAMP3NPY2RNPY4RNPY5R
SCHEMBL29695646 0.90 NPY2R (0.63) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30607272 0.90 CALCR (0.63) CALCRRAMP3NPY2RNPY4RNPY5R
SCHEMBL30495793 0.89 CALCR (0.67) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30607449 0.89 CALCR (0.64) CALCRRAMP3NPY2RNPY4RNPY5R
SCHEMBL29489234 0.88 CALCR (0.64) CALCRRAMP3NPY2RNPY4RNPY5R
SCHEMBL29489233 0.88 CALCR (0.64) CALCRRAMP3NPY2RNPY4RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110381984-B Compositions and methods for improving sexual function 尼莫克斯股份有限公司 2023-11-28 — — CN disclosed
EP-4275688-A2 METHOD OF AMELIORATING OR PREVENTING THE WORSENING OR THE PROGRESSION OF SYMPTOMS OF BPH Nymox Corporation (BS) 2023-11-15 — — EP disclosed
CN-116785403-A Neurofilament peptides for preventing or slowing the progression of prostate cancer 尼莫克斯股份有限公司 2023-09-22 — — CN disclosed
CN-109310732-B Neurofilament peptides for preventing or slowing the progression of prostate cancer 尼莫克斯股份有限公司 2023-07-21 — — CN disclosed
CN-114099636-A Method of treating a condition requiring cell destruction or removal using peptides derived from neurofilament proteins 尼莫克斯制药公司 2022-03-01 — — CN disclosed
Send feedback